» Articles » PMID: 29525776

Determinants of Psychological Well-being in Axial Spondyloarthritis: an Analysis Based on Linked Claims and Patient-reported Survey Data

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2018 Mar 12
PMID 29525776
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study was to assess the psychological well-being and to analyse factors associated with depressive symptoms in axial spondyloarthritis (axSpA).

Methods: A stratified random sample of subjects with a diagnosis of axSpA (International Classification of Diseases, Tenth Revision, German Modification M45) was drawn from health insurance data in Germany. These persons received a postal questionnaire on disease-related, psychological and lifestyle factors as well as socioeconomic status. Additional information to verify the axSpA diagnosis was also collected. The psychological well-being was assessed by means of the 5-item WHO Well-Being Index (WHO-5), which is considered a screening tool for depression. The following established cut-offs on the WHO-5 were applied: >50: good well-being, no depressive symptoms; 29-50: mild depressive symptoms; ≤28: moderate-to-severe depressive symptoms. Information on comorbidities, drug prescriptions and non-pharmacological treatment was retrieved from claims data and linked to the questionnaire data.

Results: A total of 1736 persons with a confirmed axSpA diagnosis were included. Using the cut-offs on the WHO-5, 533 persons (31%) were found to have moderate-to-severe depressive symptoms, 479 (28%) had mild depressive symptoms and 724 (42%) had a good well-being. Multivariable logistic regression revealed that higher disease activity, higher level of functional impairment, lower income, self-reported stress and lack of exercise, and younger age represent factors associated with moderate-to-severe depressive symptoms.

Conclusions: The prevalence of depressive symptoms in axSpA subjects is high and associated with disease-related parameters, socioeconomic status and lifestyle factors. These findings highlight the need for the careful evaluation of depressive symptoms as a part of the management strategy for axSpA.

Citing Articles

COping with Rheumatic Stressors (CORS) questionnaire: validated German translation and cross-cultural adaptation for patients with axSpA.

Vaupel K, Kiefer D, Ramiro S, Kiltz U, van Lankveld W, Hammel L J Patient Rep Outcomes. 2025; 9(1):5.

PMID: 39786655 PMC: 11718023. DOI: 10.1186/s41687-024-00828-3.


Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).

Rahman P, Garrido-Cumbrera M, Rohekar S, Mallinson M, Karam E, Jovaisas A Musculoskeletal Care. 2024; 22(4):e70010.

PMID: 39658831 PMC: 11632139. DOI: 10.1002/msc.70010.


Depression, anxiety and cognitive function in persons with inflammatory rheumatic diseases: cross-sectional results from the German National Cohort (NAKO).

Callhoff J, Berger K, Albrecht K, Strangfeld A RMD Open. 2024; 10(4).

PMID: 39448206 PMC: 11499824. DOI: 10.1136/rmdopen-2024-004808.


A qualitative exploration of the patient journey in axial spondyloarthritis towards a people-centered understanding.

Berr K, Ziehfreund S, Welcker M, Biedermann T, Zink A Sci Rep. 2024; 14(1):19977.

PMID: 39198468 PMC: 11358462. DOI: 10.1038/s41598-024-70420-8.


Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS).

Garrido-Cumbrera M, Navarro-Compan V, Poddubnyy D, Sommerfleck F, Makri S, Correa-Fernandez J RMD Open. 2024; 10(2).

PMID: 38866592 PMC: 11177769. DOI: 10.1136/rmdopen-2024-004218.


References
1.
Busch M, Maske U, Ryl L, Schlack R, Hapke U . [Prevalence of depressive symptoms and diagnosed depression among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56(5-6):733-9. DOI: 10.1007/s00103-013-1688-3. View

2.
Calin A, Garrett S, Whitelock H, Kennedy L, OHea J, Mallorie P . A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994; 21(12):2281-5. View

3.
Bech P . Health-related quality of life measurements in the assessment of pain clinic results. Acta Anaesthesiol Scand. 1999; 43(9):893-6. DOI: 10.1034/j.1399-6576.1999.430906.x. View

4.
Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J . The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009; 68(6):777-83. DOI: 10.1136/ard.2009.108233. View

5.
Meesters J, Bremander A, Bergman S, Petersson I, Turkiewicz A, Englund M . The risk for depression in patients with ankylosing spondylitis: a population-based cohort study. Arthritis Res Ther. 2014; 16(5):418. PMC: 4180137. DOI: 10.1186/s13075-014-0418-z. View